Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease

NCT01925352 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Heart Disease

Interventions

DRUG: Ad-HGF

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

[object Object]